CEBPD and familial pancreatic carcinoma: Maybe more importantly, we have shown that re-expressing C/EBPδ limits pancreatic cancer cell growth in a dose-dependent manner, implying that re-expressing C/EBPδ in pancreatic ductal adenocarcinoma may limit disease progression, although this remains to be established in ongoing preclinical experimental animal studies.